380 related articles for article (PubMed ID: 26997435)
1. Immunohistochemical molecular analysis indicates hepatocellular carcinoma subgroups that reflect tumor aggressiveness.
Tsujikawa H; Masugi Y; Yamazaki K; Itano O; Kitagawa Y; Sakamoto M
Hum Pathol; 2016 Apr; 50():24-33. PubMed ID: 26997435
[TBL] [Abstract][Full Text] [Related]
2. Altered expression of AT-rich interactive domain 1A in hepatocellular carcinoma.
Abe H; Hayashi A; Kunita A; Sakamoto Y; Hasegawa K; Shibahara J; Kokudo N; Fukayama M
Int J Clin Exp Pathol; 2015; 8(3):2763-70. PubMed ID: 26045782
[TBL] [Abstract][Full Text] [Related]
3. Expression of Wnt-5a and its clinicopathological significance in hepatocellular carcinoma.
Liu XH; Pan MH; Lu ZF; Wu B; Rao Q; Zhou ZY; Zhou XJ
Dig Liver Dis; 2008 Jul; 40(7):560-7. PubMed ID: 18294932
[TBL] [Abstract][Full Text] [Related]
4. Relation among p130Cas, E-cadherin and beta-catenin expression, clinicopathologic significance and prognosis in human hepatocellular carcinoma.
Guo C; Liu QG; Yang W; Zhang ZL; Yao YM
Hepatobiliary Pancreat Dis Int; 2008 Oct; 7(5):490-6. PubMed ID: 18842495
[TBL] [Abstract][Full Text] [Related]
5. Neuron-glial antigen 2 overexpression in hepatocellular carcinoma predicts poor prognosis.
Lu LL; Sun J; Lai JJ; Jiang Y; Bai LH; Zhang LD
World J Gastroenterol; 2015 Jun; 21(21):6649-59. PubMed ID: 26074703
[TBL] [Abstract][Full Text] [Related]
6. Chemokine ligand 20 enhances progression of hepatocellular carcinoma via epithelial-mesenchymal transition.
Hou KZ; Fu ZQ; Gong H
World J Gastroenterol; 2015 Jan; 21(2):475-83. PubMed ID: 25593462
[TBL] [Abstract][Full Text] [Related]
7. [The significance of immunohistochemistry in the investigation of liver neoplasms: differential diagnosis, prognostic markers].
Pozharisskiĭ KM; Granov DA; Ten VP; Kubaĭbergenova AG; Leenman EE; Rasskazov AI
Vopr Onkol; 2008; 54(4):417-33. PubMed ID: 18942395
[TBL] [Abstract][Full Text] [Related]
8. Beta-catenin accumulation in the progression of human hepatocarcinogenesis correlates with loss of E-cadherin and accumulation of p53, but not with expression of conventional WNT-1 target genes.
Prange W; Breuhahn K; Fischer F; Zilkens C; Pietsch T; Petmecky K; Eilers R; Dienes HP; Schirmacher P
J Pathol; 2003 Oct; 201(2):250-9. PubMed ID: 14517842
[TBL] [Abstract][Full Text] [Related]
9. Hepatocyte nuclear factor 1β is a novel prognostic marker independent of the Milan criteria in transplantable hepatocellular carcinoma: a retrospective analysis based on tissue microarrays.
Shim JH; Lee HC; Han S; Kang HJ; Yu E; Lee SG
Liver Transpl; 2013 Mar; 19(3):336-45. PubMed ID: 23203386
[TBL] [Abstract][Full Text] [Related]
10. Down-regulated FSTL5 promotes cell proliferation and survival by affecting Wnt/β-catenin signaling in hepatocellular carcinoma.
Zhang D; Ma X; Sun W; Cui P; Lu Z
Int J Clin Exp Pathol; 2015; 8(3):3386-94. PubMed ID: 26045876
[TBL] [Abstract][Full Text] [Related]
11. Kindlin-2 promotes hepatocellular carcinoma invasion and metastasis by increasing Wnt/β-catenin signaling.
Lin J; Lin W; Ye Y; Wang L; Chen X; Zang S; Huang A
J Exp Clin Cancer Res; 2017 Sep; 36(1):134. PubMed ID: 28969700
[TBL] [Abstract][Full Text] [Related]
12. Expression of biliary antigen and its clinical significance in hepatocellular carcinoma.
Yoon DS; Jeong J; Park YN; Kim KS; Kwon SW; Chi HS; Park C; Kim BR
Yonsei Med J; 1999 Oct; 40(5):472-7. PubMed ID: 10565259
[TBL] [Abstract][Full Text] [Related]
13. Steatotic and nonsteatotic scirrhous hepatocellular carcinomas reveal distinct clinicopathological features.
Hatano M; Ojima H; Masugi Y; Tsujikawa H; Hiraoka N; Kanai Y; Shimada K; Shinoda M; Sakamoto M
Hum Pathol; 2019 Apr; 86():222-232. PubMed ID: 30597153
[TBL] [Abstract][Full Text] [Related]
14. Hepatocellular carcinomas expressing 'stemness'-related markers: clinicopathological characteristics.
Kim H; Park YN
Dig Dis; 2014; 32(6):778-85. PubMed ID: 25376296
[TBL] [Abstract][Full Text] [Related]
15. Akt phosphorylation is a risk factor for early disease recurrence and poor prognosis in hepatocellular carcinoma.
Nakanishi K; Sakamoto M; Yamasaki S; Todo S; Hirohashi S
Cancer; 2005 Jan; 103(2):307-12. PubMed ID: 15593087
[TBL] [Abstract][Full Text] [Related]
16. Activation of hepatic stem cell marker EpCAM by Wnt-beta-catenin signaling in hepatocellular carcinoma.
Yamashita T; Budhu A; Forgues M; Wang XW
Cancer Res; 2007 Nov; 67(22):10831-9. PubMed ID: 18006828
[TBL] [Abstract][Full Text] [Related]
17. Expression of proteins associated with hypoxia and Wnt pathway activation is of prognostic significance in hepatocellular carcinoma.
Srivastava S; Thakkar B; Yeoh KG; Ho KY; Teh M; Soong R; Salto-Tellez M
Virchows Arch; 2015 May; 466(5):541-8. PubMed ID: 25742908
[TBL] [Abstract][Full Text] [Related]
18. Loss of SFRP1 Expression Is Associated with Poor Prognosis in Hepatocellular Carcinoma.
Davaadorj M; Imura S; Saito YU; Morine Y; Ikemoto T; Yamada S; Takasu C; Hiroki T; Yoshikawa M; Shimada M
Anticancer Res; 2016 Feb; 36(2):659-64. PubMed ID: 26851021
[TBL] [Abstract][Full Text] [Related]
19. High alpha-fetoprotein level correlates with high stage, early recurrence and poor prognosis of hepatocellular carcinoma: significance of hepatitis virus infection, age, p53 and beta-catenin mutations.
Peng SY; Chen WJ; Lai PL; Jeng YM; Sheu JC; Hsu HC
Int J Cancer; 2004 Oct; 112(1):44-50. PubMed ID: 15305374
[TBL] [Abstract][Full Text] [Related]
20. DACH1 is a novel predictive and prognostic biomarker in hepatocellular carcinoma as a negative regulator of Wnt/β-catenin signaling.
Liu Y; Zhou R; Yuan X; Han N; Zhou S; Xu H; Guo M; Yu S; Zhang C; Yin T; Wu K
Oncotarget; 2015 Apr; 6(11):8621-34. PubMed ID: 25940701
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
